Page last updated: 2024-08-17

adenosine monophosphate and Precordial Catch

adenosine monophosphate has been researched along with Precordial Catch in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Agostini, C; Bernardo, P; Caniato, F; Cappelli, F; Di Filippo, C; Di Mario, C; Mattesini, A; Meucci, F; Sori, A; Stolcova, M	1

Other Studies

1 other study(ies) available for adenosine monophosphate and Precordial Catch

Article	Year
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty. Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 04-01, Volume: 22, Issue:4 Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment	2021

Article

Year

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 04-01, Volume: 22, Issue:4

Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment

2021